The San Jose Biocenter sponsors a morning presentation and Q&A session with representatives from pharmaceutical giant Abbott. From the event description:
“In this session, senior members from Abbott’s team will talk to potential partners or licensees to first explain what they are looking for in collaborations, particularly, to enable preclinical drug discovery (emerging targets/biology, technologies and early stage compounds/antibodies) and diagnostics.
Preclinical Pharmaceutical Interests:
- Immunology (rheumatoid arthritis, osteoarthritis)
- Neuroscience (schizophrenia, neurodegenerative diseases)
- Pain (pain associated osteoarthritis, post-operative, neuropathic states and cancer)
- Oncology (novel targets and mechanisms described in brochure)
- Renal Diseases (diabetic nephropathy and chronic kidney disease)
- Biologics · Enabling Drug Discovery Technologies and Drug Delivery approaches
Diagnostics Interests
- Next Generation Sequencing Technology
- Nucleic Acid Sample Preparation Technology
- Microfluidics (including immunodiagnostics, Point of Care, Hematology and molecular diagnostic applications)
- Label Free detection based BioSensors for nucleic acid and immunoassay applications
Xconomy readers are eligible to register at the partner network rate. Register here: http://meetabbott-xcon.eventbrite.com